NCT04629781 2024-08-01
Open-label Dose Escalation Phase 1b Trial of a New Micellar Docetaxel Compound in Patients With mCRPC
Swiss Cancer Institute
Phase 1 Terminated
Swiss Cancer Institute
Tulane University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Bayer